Conferences & Events

Found 111,158 articles

• Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALSSOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United States

  3/23/2023

  Biogen Inc. announced the outcome of the U.S. Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1 amyotrophic lateral sclerosis.

• Anaveon announces presentation of a novel development compound at the 2023 American Association for Cancer Research Annual Meeting

  3/23/2023

  Anaveon, a clinical stage, immuno-oncology company, announced that it will present a poster on ANV600 at the American Association for Cancer Research 23rd Annual Meeting being held from Friday, April 14, 2023, to Wednesday, April 19, 2023, in Orlando, Florida.

• Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting

  3/23/2023

  Sosei Group Corporation announces the election of Ms. Eiko Tomita to the Board of Directors as an Independent External Director, and the promotion of Ms. Candelle Chong to Executive Vice President and Chief of Staff at the Company’s 33rd Annual Shareholders’ Meeting and a subsequent Board of Directors meeting, held in Tokyo.

• Journey Medical Corporation to Announce Year End 2022 Financial Results on March 29, 2023Company to host conference call to discuss financial results and provide a corporate update on March 29, 2023 at 4:30 p.m. ET

  3/22/2023

  Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, announced the Company will release its year end 2022 financial results after the U.S. financial markets close on Wednesday, March 29, 2023.

• AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

  3/22/2023

  AmbioPharm, a worldwide leader in peptide API CDMO services, to host a workshop on sustainable peptide manufacturing at Biologics 2023 taking place in London, UK on March 29, 2023.

• CONMED Corporation Announces Annual Meeting of Stockholders - March 22, 2023

  3/22/2023

  CONMED Corporation announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually.

• UCLA/Luskin Orthopaedic Institute for Children to Host Professional Conference and Family Forum for National Cerebral Palsy Awareness Day on March 25, 2023

  3/22/2023

  Cerebral palsy is the most common childhood physical disability in the United States and throughout the world.

• Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences - March 22, 2023

  3/22/2023

  Gracell Biotechnologies Inc. announced that the management team will participate in two upcoming investor conferences.

• Dewpoint Therapeutics partners with Novo Nordisk to explore the field of biomolecular condensates to treat insulin resistance and diabetes progression

  3/22/2023

  Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint's discovery platform related to biomolecular condensates to treat insulin resistance and diabetic complications.

• Groups Around the World Work to Eliminate Hepatitis C by Meeting People Where They Are

  3/22/2023

  Every Friday for more than two years, a community church in North Wales, U.K., would transform into a one-stop shop of social services for people experiencing homelessness.

• EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting

  3/22/2023

  Saluda Medical Pty Limited announced that the EVOKE 36-month Study received the Outstanding Achievement in Research Award at the 25th annual meeting of the American Society of Interventional Pain Physicians in National Harbor, MD.

• Eisai to Present New Lecanemab Data, Including Research Evaluating Safety Profile, Clinical Outcomes and Quality of Life Measures, as Well as Other Important Alzheimer's Disease Research, at the AD/PD™ 2023 Annual Meeting

  3/22/2023

  Eisai Co., Ltd. announced the company will present the latest findings on lecanemab, Eisai's anti-amyloid beta protofibril* antibody for the treatment of Alzheimer's disease, at the 2023 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders from March 28-April 1 in Gothenburg, Sweden and virtually.

• Sage Therapeutics to Present at the Stifel 2023 CNS Days

  3/22/2023

  Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced that the Company will present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023, at 11:00 a.m. ET.

• Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023

  3/22/2023

  Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced that the company will present its VISTA clinical program at the American Association for Cancer Research Annual Meeting 2023, to be held onsite in Orlando, Florida on April 14-19, 2023.

• Alzheon to Present Biomarker, Brain Preservation and Clinical Effects of Oral Tablet ALZ-801 (Valiltramiprosate) at Upcoming AD/PD 2023 Conference in Gothenburg, Sweden

  3/22/2023

  Alzheon, Inc. announced that it will be presenting interim findings from an ongoing Phase 2 study evaluating ALZ-801 tablet at the upcoming AD/PD 2023 Conference to be held from March 28 – April 1, 2023 in Gothenburg, Sweden.

• XNK presents at the 8th Innate Killer Summit in La Jolla, San Diego

  3/22/2023

  XNK Therapeutics AB announced its extensive participation at the 8th Annual Innate Killer Summit in La Jolla, San Diego, CA, March 28-30.

• Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023

  3/22/2023

  RELIEF THERAPEUTICS Holding SA announces survey results identifying preferred urea cycle disorder treatment attributes from its collaboration partner ACER Therapeutics, Inc.

• IRLAB: Invitation to symposium on Parkinson's Disease and its Management Dilemma at the AD/PD(TM) 2023 on March 31, 2023

  3/22/2023

  IRLAB Therapeutics AB announced an invitation to its industry symposium at the AD/PD™ 2023 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders on Friday, March 31, 2023.

• Gain Therapeutics to Participate in Virtual Fireside Chat On Computational Biology in Drug Discovery with Key Opinion Leaders

  3/22/2023

  Gain Therapeutics, Inc. today announced that it will participate in a virtual panel discussion on recent advances in AI-enabled computational biology and the future of drug discovery.

• Avenge Bio Announces Presentations at Two Key Upcoming Annual Conferences

  3/22/2023

  Avenge Bio, Inc. today announced their posters were selected for presentation at the Society of Gynecologic Oncology's (SGO) 2023 Annual Meeting on Women's Cancer in Tampa, Florida on March 25-28, 2023